Michael Neely
Cited by
Cited by
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ...
The Lancet Infectious Diseases 14 (6), 498-509, 2014
More codeine fatalities after tonsillectomy in North American children
LE Kelly, M Rieder, J van den Anker, B Malkin, C Ross, MN Neely, ...
Pediatrics 129 (5), e1343-e1347, 2012
Accurate detection of outliers and subpopulations with Pmetrics, a non-parametric and parametric pharmacometric modeling and simulation package for R
M Neely, M van Guilder, W Yamada, A Schumitzky, R Jelliffe
Therapeutic drug monitoring 34 (4), 467, 2012
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents
TJ Walsh, PC Adamson, NL Seibel, PM Flynn, MN Neely, C Schwartz, ...
Antimicrobial agents and chemotherapy 49 (11), 4536-4545, 2005
Are vancomycin trough concentrations adequate for optimal dosing?
MN Neely, G Youn, B Jones, RW Jelliffe, GL Drusano, KA Rodvold, ...
Antimicrobial agents and chemotherapy 58 (1), 309-316, 2014
Voriconazole pharmacokinetics and pharmacodynamics in children
M Neely, T Rushing, A Kovacs, R Jelliffe, J Hoffman
Clinical infectious diseases 50 (1), 27-36, 2010
Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients
DF Florescu, SA Pergam, MN Neely, F Qiu, C Johnston, SS Way, J Sande, ...
Biology of Blood and Marrow Transplantation 18 (5), 731-738, 2012
Prospective trial on the use of trough concentration versus area under the curve to determine therapeutic vancomycin dosing
MN Neely, L Kato, G Youn, L Kraler, D Bayard, M van Guilder, ...
Antimicrobial agents and chemotherapy 62 (2), 2018
Innovative approaches to optimizing the delivery of vancomycin in individual patients
MP Pai, M Neely, KA Rodvold, TP Lodise
Advanced drug delivery reviews 77, 50-57, 2014
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected …
PENPACT-1 (PENTA 9/PACTG 390) Study Team
The Lancet infectious diseases 11 (4), 273-283, 2011
Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy
MN Neely, L Benning, J Xu, HD Strickler, RM Greenblatt, H Minkoff, ...
Journal of acquired immune deficiency syndromes (1999) 44 (1), 38, 2007
Why has model‐informed precision dosing not yet become common clinical reality? Lessons from the past and a roadmap for the future
AS Darwich, K Ogungbenro, AA Vinks, JR Powell, JL Reny, N Marsousi, ...
Clinical Pharmacology & Therapeutics 101 (5), 646-656, 2017
International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious …
JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ...
Lancet Infect Dis 14 (6), 498-509, 2014
Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients
LS Eiland, TM English, EH Eiland III
Annals of Pharmacotherapy 45 (5), 582-589, 2011
The exciting future of antifungal therapy
MN Neely, MA Ghannoum
European Journal of Clinical Microbiology and Infectious Diseases 19 (12 …, 2000
Pharmacokinetics and safety of caspofungin in older infants and toddlers
M Neely, HS Jafri, N Seibel, K Knapp, PC Adamson, SK Bradshaw, ...
Antimicrobial agents and chemotherapy 53 (4), 1450-1456, 2009
Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian
T Tatarinova, M Neely, J Bartroff, M van Guilder, W Yamada, D Bayard, ...
Journal of pharmacokinetics and pharmacodynamics 40 (2), 189-199, 2013
Improved tacrolimus target concentration achievement using computerized dosing in renal transplant recipients–a prospective, randomized study
E Størset, A Åsberg, M Skauby, M Neely, S Bergan, S Bremer, K Midtvedt
Transplantation 99 (10), 2158, 2015
Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy
TW Felton, JA Roberts, TP Lodise, M Van Guilder, E Boselli, MN Neely, ...
Antimicrobial agents and chemotherapy 58 (7), 4094-4102, 2014
Impact of bolus dosing versus continuous infusion of piperacillin and tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa
TW Felton, J Goodwin, L O'Connor, A Sharp, L Gregson, J Livermore, ...
Antimicrobial agents and chemotherapy 57 (12), 5811-5819, 2013
The system can't perform the operation now. Try again later.
Articles 1–20